Alfuzosin Hydrochloride
Product Images NDC 63629-7907

Product Visual Gallery

This gallery contains 11 technical images submitted to the FDA as part of the official labeling for Alfuzosin Hydrochloride (NDC 63629-7907). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Ef35abcf E0b6 4551 84cf A689ad11e6cd 01

Chemical structure of Alfuzosin hydrochloride, showing its molecular composition and arrangement with atoms labeled including nitrogen, oxygen, and carbon groups, as well as the hydrochloride (HCl) moiety.*

FDA Label Image

Ef35abcf E0b6 4551 84cf A689ad11e6cd 02

A pharmacokinetic line graph showing Alfuzosin plasma concentration (ng/mL) over time (hours) for fed and fasted states. The graph displays higher plasma concentrations under fed conditions compared to fasted, with time on the x-axis (0 to 24 hours) and concentration on the y-axis (0 to 14 ng/mL), including error bars at data points.*

FDA Label Image

Ef35abcf E0b6 4551 84cf A689ad11e6cd 03

A line graph showing the mean change over days of treatment (0, 28, 56, 84) comparing placebo and Alfuzosin hydrochloride extended-release tablets. The graph indicates a greater negative mean change with Alfuzosin hydrochloride compared to placebo, with statistical significance noted at p < 0.001.*

FDA Label Image

Ef35abcf E0b6 4551 84cf A689ad11e6cd 04

A line graph showing mean change over days of treatment comparing Placebo (N=152) and Alfuzosin hydrochloride extended-release tablets (N=137). The x-axis represents days of treatment (0, 28, 56, 84), and the y-axis represents mean change from 0 to -7. Alfuzosin hydrochloride shows greater mean change than placebo across the treatment period, with a statistically significant difference marked at day 84 (p < 0.01).*

FDA Label Image

Ef35abcf E0b6 4551 84cf A689ad11e6cd 05

A line graph comparing mean change over days of treatment between placebo and Alfuzosin hydrochloride extended-release tablets, showing greater mean change reduction with Alfuzosin over 84 days. The graph includes sample sizes (N=150 placebo, N=151 Alfuzosin) and indicates statistical significance at day 84 (p < 0.01).*

FDA Label Image

Ef35abcf E0b6 4551 84cf A689ad11e6cd 06

A line graph comparing mean change in mL/s over days of treatment between placebo (N=167) and Alfuzosin hydrochloride extended-release tablets (N=170). The graph shows consistent higher mean change for Alfuzosin hydrochloride at days 28, 56, and 84, with a significance indicator (***p < 0.001). X-axis is days of treatment, Y-axis is mean change mL/s.*

FDA Label Image

Ef35abcf E0b6 4551 84cf A689ad11e6cd 07

Line chart comparing mean change in ml/s over days of treatment between placebo (N=147) and Alfuzosin hydrochloride extended-release tablets (N=136). The x-axis shows days of treatment (0 to 84), and the y-axis represents mean change in ml/s (0 to 3). Data points show increasing mean change over time for both groups, with the Alfuzosin group having consistently higher values, and a statistically significant difference noted at day 84 (p<0.05).*

FDA Label Image

Ef35abcf E0b6 4551 84cf A689ad11e6cd 08

A line graph comparing mean change in mL/s over days of treatment (0, 14, 28, 56, 84) between placebo and Alfuzosin hydrochloride extended-release tablets. The graph shows data points for placebo (triangles) and Alfuzosin hydrochloride (squares), with no statistically significant difference (NS, p > 0.05) between the groups.*

FDA Label Image

Ef35abcf E0b6 4551 84cf A689ad11e6cd 09

FDA Label Image

Ef35abcf E0b6 4551 84cf A689ad11e6cd 10

FDA Label Image

Label Image (Lbl636297907)

Label for Alfuzosin HCl ER 10 mg tablet by Bryant Ranch Prepack, NDC 63629-7907-1. The label states it is a white, round tablet, packaged in a quantity of 90. It compares to Uroxatral 10 mg tablet from Unichem Laboratories Ltd. Storage instructions note to keep at room temperature (20-25°C) and out of reach of children.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.